To determine if the targeted inhibition of c-FLIP exhibited similar specificity for tumour cells, mammary epithelial cell viability was assessed in non-tumourgenic c-FLIP-deficient mouse mammary glands, transformed murine cell lines and in the human breast cell line MCF-10A. The gene discussed is CFLAR; the disease is neoplasm.